Seeking Alpha

It has been nine months since I first learned about Medical Marijuana, Inc. (OTCPK:MJNA), the first publicly-traded company focused on cannabis (following its 2009 reverse-merger) and clearly the most popular name in the sector, with a purported 40K shareholders earlier this year and over 6500 Seeking Alpha readers signed up for alerts. I have gotten to know the company very well since then, but, even after sharing my thoughts here twenty times, there is never a shortage of twists and turns in this exciting drama. At a price of $0.135 (market cap of about $130mm), down from $0.50 in February and from about $0.25 at the peak this summer but still up from $0.10 at the end...

Only subscribers can access this article, which is part of the PRO research library covering 3,741 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: